Nhu Hoang, DPM
Podiatrist · New Orleans, LANPI 1518526334
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,415 of the $2,574 with a category attached, or 93.9%. ALON Medical Technology accounts for 93.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $2,406 and has fallen 97.3% since, to $65 in 2025.
Across 12 payments — averaging $214.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ALON Medical Technology$2K
- Novo Nordisk$53
- ARS Pharmaceuticals Operations, Inc.$24
- Bayer$23
- Teva Pharmaceuticals USA, Inc.$18
- Melinta Therapeutics, LLC$18
- plus $31 from 2 others
What the payments were for
- Food & beverage$1586%
- Education$2,41594%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ALON Medical Technology | 3 | $2,406 |
| Novo Nordisk | 3 | $53 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| Bayer | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Melinta Therapeutics, LLC | 1 | $18 |
| OPKO Pharmaceuticals, LLC | 1 | $15 |
| Kerecis Limited | 1 | $15 |
How this compares
$2,574 in reported general payments places this provider in the 55th percentile of 68 podiatrist providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CiclopiroxCiclopirox Olamine | 20 | $1,231 |
| Ammonium Lactate | 25 | $383 |
| Diclofenac Sodium | 19 | $375 |
| Doxycycline Hyclate | 12 | $108 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $80 |
| Meloxicam | 26 | $65 |
| Methylprednisolone | 12 | $60 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $43 |
| Levofloxacin | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in New Orleans
- Nneka MekaNew Orleans$9K
- Dayna BoltonNew Orleans$9K
- Edward LangNew Orleans$7K
- Sandreka JonesNew Orleans$6K
- Erin BujolNew Orleans$3K
- Giang NguyenNew Orleans$2K
- Joshua NeesonNew Orleans$1K
- Maxime SavardKenner$74K
- David TranMonroe$24K
- Tyler TewilliagerHouma$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.